By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Advanced Wound Closure’s New Players
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Advanced Wound Closure’s New Players
Medical DevicesMedical InnovationsSpecialtiesTechnology

Advanced Wound Closure’s New Players

PatrickDriscoll
PatrickDriscoll
Share
3 Min Read
sealants-global-market
SHARE

The global market for products in “wound securement,” or the aggregate of products that are related to the closure and healing of wounds, is dominated by traditional products — sutures and the more recent clips and staples. However, as simple and effective as these are, particularly since their use is engrained in the skillsets of practicing surgeons, advances in wound closure, hemostasis and even anti-adhesion are challenging the entrenched positions of suture, staple and clip suppliers.  

The global market for products in “wound securement,” or the aggregate of products that are related to the closure and healing of wounds, is dominated by traditional products — sutures and the more recent clips and staples. However, as simple and effective as these are, particularly since their use is engrained in the skillsets of practicing surgeons, advances in wound closure, hemostasis and even anti-adhesion are challenging the entrenched positions of suture, staple and clip suppliers.  

Fibrin and other sealants have found acceptance in use by surgeons seeking tighter wound sealing, faster healing, less scarring and other benefits.  Hemostatic agents have proven highly versatile (in a range of clinical settings from the OR to the battlefield) in rapidly stopping bleeds in a way that traditional wound closure cannot. The end result of surgery also demands that the surgery itself cause a minimum of complications, and products in anti-adhesion (many actually being sealant products that are actually effective in what one might consider the “opposite” role) have proved effective in this capacity.

But old habits die hard, so very high caseload of wound closure is still addressed via sutures, staples and clips.  Consequently, the global market for wound closure and related products has companies like Ethicon (J&J) holding big pieces of the pies.

More Read

23andMe FDA warning
BioPharma Beat: 23andMe – Now What?
Are Wearables the Future of Clinical Trials?
Making It Easier for Older People to Live at Home
What Are The Risks Of Bruxism And How Can You Prevent Them?
Hearts in Healthcare – Rehumanizing the Healthcare System

sealants-global-market

Legend:

A: Ethicon/J&J
B: Covidien
C: B. Braun
D: Others
E: 3M
F: CSL Behring
G: Pfizer
H: Equimedical BV
I: Baxter
J: Cryolife
K: AdMedSol
L: Genzyme Biosurgery

Source: “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2012-2017″, MedMarket Diligence Report #S190.

TAGGED:emergency medicinewound closurewound technology
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

weight loss surgeon
How to Choose the Best Surgeon for Weight Loss Surgery
Weight Loss Wellness
February 11, 2026
aging care healthcare system
The Growing Role of Terminal Care Specialists in a Rapidly Aging Healthcare System
Global Healthcare Senior Care
February 11, 2026
Why Trauma and Addiction Are Linked and How Effective Programs Treat Both
Addiction Addiction Recovery
February 10, 2026
car accident injuries
The Hidden Healthcare Impact of Car Accident Injuries
News Policy & Law
February 8, 2026

You Might also Like

Health Savings Through Technology Deployment

August 17, 2012
personalized medicine
Health ReformMedical InnovationsNewsPolicy & LawPublic Health

Sequencing the Insurance Genome

February 5, 2015

Who’s Confused? Angry Patients or Physicians?

August 17, 2011
Image
eHealthTechnology

Digitalization Transforming Healthcare: The Era of Health 2.0

November 7, 2016
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?